Page last updated: 2024-08-17

medroxyprogesterone acetate and Cancer of Head

medroxyprogesterone acetate has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amadori, D; Falcini, F; Flamini, E; Frassineti, GL; Maltoni, M; Nanni, O; Piccinini, C; Riccobon, A	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Cancer of Head

Article	Year
Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cell Count; Cisplatin; Fluorouracil; Granulocytes; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Macrophages; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Mitosis; Vincristine	1992

Article

Year

Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer.

European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cell Count; Cisplatin; Fluorouracil; Granulocytes; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Macrophages; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Mitosis; Vincristine

1992